Role of Biomarkers in Periprosthetic Joint Infections

Akcaalan S., Ozaslan H. I., Caglar C., ŞİMŞEK M. E., Citak M., AKKAYA M.

Diagnostics, vol.12, no.12, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 12 Issue: 12
  • Publication Date: 2022
  • Doi Number: 10.3390/diagnostics12122958
  • Journal Name: Diagnostics
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, INSPEC, Directory of Open Access Journals
  • Keywords: periprosthetic joint infection, biomarker, blood, synovial fluid
  • Ankara Yıldırım Beyazıt University Affiliated: Yes


Periprosthetic joint infection (PJI) is one of the most serious complications after joint arthroplasty. The incidence rate of PJI after total joint replacement is 1–3%. Although there are different guidelines and diagnostic criteria used to diagnose PJI, diagnosing PJI is a highly difficult process for orthopedists. The current Musculoskeletal Infection Society (MSIS) criteria are widely used for the diagnosis of PJI. These criteria include results from blood/synovial fluid tests, physical examination, and histological and microbiological analyses of intra-operative samples. However, there is currently no blood or synovial test that can definitively diagnose PJI. To make a more effective diagnosis of PJI, a large number of studies have explored and continue to investigate biomarkers. This review aims to provide general information about serum and synovial markers used for the diagnosis of PJI that may be used to create a database to guide researchers in new studies.